Stock Price Quote

SANOFI CONSUMER HEALTHCARE INDIA LTD.

NSE : SANOFICONRBSE : 544250ISIN CODE : INE0UOS01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE5088.50-50.2 (-0.98 %)
PREV CLOSE ( ) 5138.70
OPEN PRICE ( ) 5117.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 152
TODAY'S LOW / HIGH ( )5055.00 5130.00
52 WK LOW / HIGH ( )4360.3 5954
NSE5090.50-37 (-0.72 %)
PREV CLOSE( ) 5127.50
OPEN PRICE ( ) 5150.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 5090.50 (20)
VOLUME 1431
TODAY'S LOW / HIGH( ) 5060.00 5150.00
52 WK LOW / HIGH ( )4211.55 5894.5
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-05 2023
Management Info
Amit Jain - Chairman Himanshu Bakshi - Managing Director
Registered Office

Address Unit 1104, 11th Floor, Godrej Two,Pirojshanagar, Eastern Express Highway,Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone 022 45288855

Email igrc.schil@sanofi.com

Website www.sanofi.in

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

13Jun Sanofi Consumer Healthcare India infor
Sanofi Consumer Healthcare India has informed that the exchange has rece..
05May Updates on Open Offer
Citigroup Global Markets India Pvt Ltd ("Manager to the Offer") has subm..
02May Updates on Open Offer
Citigroup Global Markets India Pvt Ltd ("Manager to the Offer") has subm..
30Apr Updates on Open Offer
Citigroup Global Markets India Pvt. Ltd. ("Manager to the Offer") has su..
24Apr Updates on Open Offer
Citigroup Global Markets India Pvt. Ltd. ("Manager to the Offer") has su..

Financials

in Millions
QTR Mar 25 ANNUAL 24
Net Profit5001810
Gross Profit 668 2468
Operating Profit 6922836
Net Sales 17267245

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Blue Jet Healthcare (BSE)
peergroup  1012.00 (4.21%)
M.Cap ( in Cr)17554.70
Jubilant Pharmova (BSE)
peergroup  1234.90 (2.87%)
M.Cap ( in Cr)19669.63
Mercury Laboratories (BSE)
peergroup  888.00 (3.71%)
M.Cap ( in Cr)106.56
Sanjivani Paranteral (BSE)
peergroup  247.40 (11.39%)
M.Cap ( in Cr)303.91
Abbott India (BSE)
peergroup  34148.85 (0.06%)
M.Cap ( in Cr)72563.92

Shareholding Pattern

FI/BANKS/INSURANCE 9.78%
PROMOTERS 60.4%
MUTUAL FUNDS/UTI 15.09%
NON-INSTITUTION 10.17%
GOVERNMENT 0%
FII 0%

About Sanofi Consumer Healthcare India Ltd.

Sanofi Consumer Healthcare India Ltd. was incorporated in the year 2023. Its today's share price is 5088.5. Its current market capitalisation stands at Rs 11719.13 Cr. In the latest quarter, company has reported Gross Sales of Rs. 7567 Cr and Total Income of Rs.7375 Cr. The company's management includes Carol Ann Stewart, Stanislas Camart, Maithilee Kaizad Mistry, Himanshu Bakshi, Suparna Pandhi, Shobinder Duggal, Amit Jain, Nikunj Savaliya.

It is listed on the BSE with a BSE Code of 544250 , NSE with an NSE Symbol of SANOFICONR and ISIN of INE0UOS01011. It's Registered office is at Unit 1104, 11th Floor, Godrej Two,Pirojshanagar, Eastern Express Highway,Vikhroli (East)Mumbai-400079, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Kalyaniwalla & Mistry LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.